Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.5K Buy
+11,725
New +$44.1K ﹤0.01% 1940
2026
Q1
Sell
-95,835
Closed -$583K 2475
2025
Q4
$583K Buy
+95,835
New +$872K 0.01% 1246

Other funds holding XGN

Jump Financial's XGN Position: Q2 2026 in Review

Jump Financial opened a new position in Exagen (XGN) in Q2 2026: 11,725 shares worth $54.5K. The stake represents ﹤0.01% of the portfolio and ranks #1940 among its holdings. This is a return to the name: Jump Financial previously reported a position in XGN as recently as Q4 2025.

Jump Financial first reported a position in XGN in Q4 2025 and has held it in 2 quarters since. The position peaked at $583K in Q4 2025. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Jump Financial held 11,725 shares of Exagen worth $54.5K as of Q2 2026.
  • Exagen was a new Jump Financial position in Q2 2026.
  • Exagen made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1940 holding.
  • Jump Financial first reported a position in Exagen in Q4 2025 and has held it in 2 quarters since.
  • Jump Financial's Exagen position peaked at $583K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.